PARIS, May 25 (Reuters) - A French consortium announced on
Monday the launch of the production phase for a saliva-based
screening test to detect the COVID-19 coronavirus.
The consortium said the test would be performed by a
healthcare professional and involves collecting less than 1
millilitre of saliva from a patient. The sample is then
deposited in two tubes heated to 65C, and a subsequent reading
screens the tested patients for the presence of the virus.
The consortium - comprised of French companies Vogo
ALVGO.PA , SKILLCELL and the CNRS SYS2DIAG laboratory - hoped
its 'EasyCov' product would enter the French market from
mid-June onwards.
(Reporting by Sudip Kar-Gupta; Editing by Kim Coghill)
((sudip.kargupta@thomsonreuters.com; +33 1 49 49 53 84;))